BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35158412)

  • 1. Effect of nirmatrelvir/ritonavir on calcineurin inhibitor levels: Early experience in four SARS-CoV-2 infected kidney transplant recipients.
    Wang AX; Koff A; Hao D; Tuznik NM; Huang Y
    Am J Transplant; 2022 Aug; 22(8):2117-2119. PubMed ID: 35158412
    [No Abstract]   [Full Text] [Related]  

  • 2. Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.
    Salerno DM; Jennings DL; Lange NW; Kovac DB; Shertel T; Chen JK; Hedvat J; Scheffert J; Brown RS; Pereira MR
    Am J Transplant; 2022 Aug; 22(8):2083-2088. PubMed ID: 35278260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19.
    Boland L; Devresse A; Monchaud C; Briol S; Belaiche S; Giguet B; Couzi L; Thaunat O; Esposito L; Meszaros M; Roussoulieres A; Haufroid V; Le Meur Y; Lemaitre F
    Transpl Int; 2024; 37():12360. PubMed ID: 38596505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies.
    Tang Y; Li Y; Song T
    Front Immunol; 2023; 14():1150341. PubMed ID: 37081880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.
    Schneider J; Wobser R; Kühn W; Wagner D; Tanriver Y; Walz G
    BMC Nephrol; 2023 Apr; 24(1):99. PubMed ID: 37061677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir.
    Gonzalez-García R; Roma JR; Rodríguez-García M; Arranz N; Ambrosioni J; Bodro M; Castel MÁ; Cofan F; Crespo G; Diekmann F; Farrero M; Forner A; LLigoña A; Marcos MÁ; Moreno A; Ruiz P; Soy D; Brunet M; Miró JM; Tuset M
    Clin Microbiol Infect; 2023 May; 29(5):655.e1-655.e4. PubMed ID: 36641051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct cases with COVID-19 in kidney transplant recipients.
    Kim Y; Kwon O; Paek JH; Park WY; Jin K; Hyun M; Lee JY; Kim HA; Han S
    Am J Transplant; 2020 Aug; 20(8):2269-2275. PubMed ID: 32337859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Saving lives with nirmatrelvir/ritonavir one transplant patient at a time".
    Belden KA; Yeager S; Schulte J; Cantarin MPM; Moss S; Royer T; Coppock D
    Transpl Infect Dis; 2023 Apr; 25(2):e14037. PubMed ID: 36847419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry.
    Montero C; Torres R; Benavidez C; Garcia P; Jimenez S; Yomayusa N; Gayon D; Perez J; Rosselli D; Restrepo H; Alvarez-Moreno C
    Nefrologia (Engl Ed); 2023; 43(6):757-764. PubMed ID: 36681519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.
    Young C; Papiro T; Greenberg JH
    Pediatr Nephrol; 2023 Apr; 38(4):1387-1388. PubMed ID: 35982345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitors revisited: A new paradigm for COVID-19?
    Hage R; Steinack C; Schuurmans MM
    Braz J Infect Dis; 2020; 24(4):365-367. PubMed ID: 32603679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.
    Dewey KW; Yen B; Lazo J; Seijo L; Jariwala R; Shah RJ; Quan D; Carpenter B; Paul Singer J; Breen K; Hays S; Florez R
    Transplantation; 2023 May; 107(5):1200-1205. PubMed ID: 36525555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients.
    Xu X; Zhang H; Liu L; Fu Q; Wu C; Lin X; Tang K; Wang C; Chen P
    Eur J Clin Pharmacol; 2024 May; ():. PubMed ID: 38691139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19].
    Remport Á; Gerlei Z; Cseprekál O; Wagner L; Földes K; Marton A; Patonai A; Török S; Haboub-Sandil A; Varga M; Doros A; Smudla A; Fazakas J; Kóbori L
    Orv Hetil; 2020 Aug; 161(32):1310-1321. PubMed ID: 32750019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2.
    Devresse A; Sébastien Briol ; De Greef J; Lemaitre F; Boland L; Haufroid V; Scohy A; Kabamba B; Yombi JC; Belkhir L; Darius T; Buemi A; De Potter K; Mantegazza R; Bearzatto B; Goffin E; Kanaan N
    Kidney Int Rep; 2022 Nov; 7(11):2356-2363. PubMed ID: 36060621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report.
    Prikis M; Cameron A
    Transplant Proc; 2022; 54(6):1557-1560. PubMed ID: 35599203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Clinical Outcomes of Pregnant Patients Treated With Nirmatrelvir and Ritonavir for Acute SARS-CoV-2 Infection.
    Garneau WM; Jones-Beatty K; Ufua MO; Mostafa HH; Klein SL; Burd I; Gebo KA
    JAMA Netw Open; 2022 Nov; 5(11):e2244141. PubMed ID: 36445705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Nirmatrelvir/Ritonavir and Tacrolimus in a Kidney Transplant Recipient With COVID-19.
    Lindauer KE; Hamel AG
    Am Fam Physician; 2022 Jun; 105(6):569-570. PubMed ID: 35704835
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series.
    Guzmán Cordero C; Saez-Torres de Vicente M
    Eur J Hosp Pharm; 2024 Feb; 31(2):175-177. PubMed ID: 36535689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case.
    Guyon J; Novion M; Fulda V; Ducint D; Molimard M; Couzi L; Kaminski H; Salvo F; Bouchet S
    J Am Soc Mass Spectrom; 2022 Oct; 33(10):1975-1981. PubMed ID: 36084269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.